These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19716365

  • 21. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
    Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C.
    Brain Res; 2006 Jun 13; 1094(1):38-46. PubMed ID: 16697978
    [Abstract] [Full Text] [Related]

  • 22. Neuroprotective approaches in the animal model.
    Kerschensteiner M.
    Drug Res (Stuttg); 2013 Nov 13; 63 Suppl 1():S7. PubMed ID: 24242040
    [No Abstract] [Full Text] [Related]

  • 23. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov 13; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Nov 13; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 29. Glucocorticoids in the control of neuroinflammation.
    Tischner D, Reichardt HM.
    Mol Cell Endocrinol; 2007 Sep 15; 275(1-2):62-70. PubMed ID: 17555867
    [Abstract] [Full Text] [Related]

  • 30. Experimental models of multiple sclerosis.
    Pachner AR.
    Curr Opin Neurol; 2011 Jun 15; 24(3):291-9. PubMed ID: 21519255
    [Abstract] [Full Text] [Related]

  • 31. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D, Slavin S.
    J Neurol Sci; 2004 Aug 15; 223(1):59-64. PubMed ID: 15261562
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.
    Aharoni R.
    Expert Rev Clin Immunol; 2013 May 15; 9(5):423-40. PubMed ID: 23634737
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr 15; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis.
    Kipp M, Beyer C.
    Front Neuroendocrinol; 2009 Jul 15; 30(2):188-200. PubMed ID: 19393685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.